PharmiWeb.com - Global Pharma News & Resources

Press Releases

Date Title Company
05-Jan-2024 AUSTIN, Texas, Jan. 04, 2024 (GLOBE NEWSWIRE) -- XBiotech Inc. today announced that it plans to expand it’s campus headquarters with the construction of a new, state-of-the-art research and development facility. XBiotech has received City of Austin approval to begin excavation for site preparation and groundwork is expected to begin 1st quarter 2024. The new four-story building, to be located close to the existing 46,000 ft2 manufacturing and R&D facility, will provide key infrastructure to supp XBiotech
05-Jan-2024 Top 10 Morpheus8 Questions Being Asked About This Skin Procedure AccessWire
05-Jan-2024 Glidewell Publishes Inaugural Edition of Integrate(TM) Magazine AccessWire
05-Jan-2024 Spiden Announces Breakthrough in Non-Invasive Glucose Monitoring, Adds Key Executive Hires and Secures $15m in Additional Funding AccessWire
05-Jan-2024 Nutriband Signs Commercial Development and Clinical Supply Agreement With Kindeva Drug Delivery for Aversa(TM) Fentanyl, an Abuse Deterrent Fentanyl Patch AccessWire
05-Jan-2024 Zen Dog Veterinary Care Expands Services to Westchester AccessWire
05-Jan-2024 Metrodora Institute Announces New Chief Scientific Officer AccessWire
05-Jan-2024 Radiance Therapeutics to Present at the Biotech Showcase 2024 in San Francisco AccessWire
05-Jan-2024 CureVac Announces Positive Phase 2 Interim Data from COVID-19 Vaccine Development Program in Collaboration with GSK Providing Strong Validation of Proprietary Technology Platform AccessWire
05-Jan-2024 CureVac Announces Positive Phase 2 Interim Data from COVID-19 Vaccine Development Program in Collaboration with GSK Providing Strong Validation of Proprietary Technology Platform CureVac
05-Jan-2024 selectION, Inc. to Present Update on Clinical Progress at the 42nd Annual J.P. Morgan Healthcare Conference in San Francisco, CA, on January 11, 2024 selectION, Inc.
05-Jan-2024 Truemed and NASM Partner for Tax-Free HSA/FSA Spending for Personal Training AccessWire
04-Jan-2024 Edesa Biotech to Participate in Dermatology Summit and JP Morgan Week AccessWire
04-Jan-2024 Dermata Expands Global Intellectual Patent Portfolio with Issuance of Japanese Patent for DMT410 for the Treatment of Hyperhidrosis AccessWire
04-Jan-2024 Recovery Delivered Expands Services to Accept Medicaid in Ohio for Online Suboxone to Treat Opioid Addiction AccessWire
04-Jan-2024 Just in Time GCP Announces Brian Guza as COO Newswire
04-Jan-2024 Just in Time GCP Announces Brian Guza as COO AccessWire
04-Jan-2024 Top 10 Tummy Tuck Surgery Questions That Women Seek Answers To AccessWire
04-Jan-2024 iTolerance, Inc. to Present at Biotech Showcase(TM) 2024 AccessWire
04-Jan-2024 Formycon to present at the 42nd Annual J.P. Morgan Healthcare Conference Formycon AG